CVC Catalyst III, a fund from CVC‘s mid-market private equity strategy, has agreed to acquire a majority stake in WillowWood Holdings Inc., a manufacturer of prosthetic products serving patients across the U.S. and key European markets.
Following the transaction, CVC Catalyst will become the majority investor, while Blue Sea Capital, the Arbogast family and management will retain significant ownership through substantial reinvestment. Co-CEOs Mahesh Mansukhani and Daniel Rubin will continue to lead the company. Founded in 1907 in Mt. Sterling, Ohio, WillowWood is a developer and manufacturer of prosthetic liners, feet, knees and related technologies. The company pioneered the prosthetic gel liner, a critical interface between a patient’s residual limb and prosthesis, and today offers approximately 1,000 SKUs along with custom liner solutions.